10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-042058`
Period End Date	20170630
Filing Date	20170810
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	enzn-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 48 Cash Flow Statement 20

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.21M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$3.50M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$127.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$270.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.91M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.83M	USD	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$815.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$3.36M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$11.27M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$15.65M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$363.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$770.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$124.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$170.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$487.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$940.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at June 30, 2017 and December 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at June 30, 2017 and December 31, 2016	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at June 30, 2017 and December 31, 2016	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$90.28M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$90.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$15.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.33M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$11.27M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$15.65M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$8.21M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$5.50M	USD	2 Qtrs
Royalties	`RoyaltyRevenue`	$6.78M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$2.27M	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$42.00K	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	2 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	-	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$6.78M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$8.21M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$5.54M	USD	2 Qtrs
Total revenues	`SalesRevenueNet`	$2.27M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$686.00K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$436.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$337.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.16M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$436.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$337.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.16M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$686.00K	USD	2 Qtrs
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.84M	USD	1 Quarter
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.38M	USD	2 Qtrs
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.44M	USD	1 Quarter
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.53M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$2.25M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.83M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$801.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$2.70M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$4.18M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.03M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.83M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.55M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.06	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.09	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.06	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.11	USD	2 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	2 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,120.00	shares	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,215.00	shares	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44,167.00	shares	2 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,215.00	shares	2 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,167.00	shares	2 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44,120.00	shares	1 Quarter

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$4.18M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.03M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.83M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.55M	USD	2 Qtrs
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$1.83M	USD	2 Qtrs
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$2.55M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$4.82M	USD	2 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$3.81M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-441.00K	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$3.57M	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-441.00K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.57M	USD	2 Qtrs
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.21M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.21M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.